• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Marijuana Stock Movers For June 19, 2024

    6/19/24 4:30:04 PM ET
    $CARA
    $OGI
    $PMD
    $VFF
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $CARA alert in real time by email

    GAINERS:

    • Elixinol Wellness (OTC:ELLXF) shares closed up 82.00% at $0.00
    • Target Group (OTC:CBDY) shares closed up 15.38% at $0.00
    • Psychemedics (NASDAQ:PMD) shares closed up 10.88% at $2.35
    • Cannabix Technologies (OTC:BLOZF) shares closed up 7.53% at $0.39
    • 4Front Ventures (OTC:FFNTF) shares closed up 5.26% at $0.09
    • EnWave (OTC:NWVCF) shares closed up 4.77% at $0.18
    • Village Farms Intl (NASDAQ:VFF) shares closed up 3.66% at $1.00
    • OrganiGram Holdings (NASDAQ:OGI) shares closed up 3.31% at $1.54

    LOSERS:

    • Global Compliance (OTC:FUAPF) shares closed down 33.33% at $0.01
    • Heritage Cannabis Holding (OTC:HERTF) shares closed down 30.00% at $0.00
    • Rocky Mountain High (OTC:RMHB) shares closed down 24.83% at $0.01
    • Pharmadrug (OTC:LMLLF) shares closed down 16.12% at $0.02
    • MJ Holdings (OTC:MJNE) shares closed down 11.46% at $0.01
    • Affinor Growers (OTC:RSSFF) shares closed down 10.38% at $0.07
    • CV Sciences (OTC:CVSI) shares closed down 9.36% at $0.06
    • Zoned Props (OTC:ZDPY) shares closed down 7.41% at $0.60
    • Nextleaf Solutions (OTC:OILFF) shares closed down 6.96% at $0.06
    • Kaya Holdings (OTC:KAYS) shares closed down 6.28% at $0.04
    • Auxly Cannabis Group (OTC:CBWTF) shares closed down 5.98% at $0.02
    • 22nd Century Group (NASDAQ:XXII) shares closed down 5.44% at $0.60
    • Cara Therapeutics (NASDAQ:CARA) shares closed down 5.30% at $0.24
    • Charlottes Web Holdings (OTC:CWBHF) shares closed down 4.97% at $0.14
    • Blueberries Medical (OTC:BBRRF) shares closed down 4.63% at $0.01
    • iAnthus Capital Hldgs (OTC:ITHUF) shares closed down 3.01% at $0.02

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $CARA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CARA
    $OGI
    $PMD
    $VFF

    CompanyDatePrice TargetRatingAnalyst
    Organigram Global Inc.
    $OGI
    1/27/2026Buy
    Canaccord Genuity
    Organigram Global Inc.
    $OGI
    7/17/2024Speculative Buy
    Canaccord Genuity
    Cara Therapeutics Inc.
    $CARA
    6/13/2024$6.00 → $1.00Buy → Hold
    Stifel
    Cara Therapeutics Inc.
    $CARA
    6/13/2024$10.00 → $1.00Buy → Hold
    Canaccord Genuity
    Cara Therapeutics Inc.
    $CARA
    6/13/2024Buy → Hold
    Needham
    Cara Therapeutics Inc.
    $CARA
    6/13/2024Buy → Neutral
    H.C. Wainwright
    Organigram Global Inc.
    $OGI
    4/15/2024Neutral → Buy
    Alliance Global Partners
    Cara Therapeutics Inc.
    $CARA
    3/8/2023$13.00 → $6.00Neutral → Underperform
    BofA Securities
    More analyst ratings

    $CARA
    $OGI
    $PMD
    $VFF
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 23, 2021 - FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them

    For Immediate Release: December 23, 2021 Today, the U.S. Food and Drug Administration authorized the marketing of 22nd Century Group Inc.’s “VLN King” and “VLN Menthol King” combusted, filtered cigarettes as modified risk tobacco products (MRTPs), which help reduce exposure to, and consumption of, nicotine for smokers who use them. These are the first combusted cigarettes to be authorized as MRTPs and the second

    12/23/21 9:06:12 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    FDA Approval for KORSUVA issued to CARA THERAPEUTICS INC

    Submission status for CARA THERAPEUTICS INC's drug KORSUVA (ORIG-1) with active ingredient DIFELIKEFALIN has changed to 'Approval' on 08/23/2021. Application Category: NDA, Application Number: 214916, Application Classification: Type 1 - New Molecular Entity

    8/24/21 12:36:58 PM ET
    $CARA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CARA
    $OGI
    $PMD
    $VFF
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Organigram Reports First Quarter Fiscal 2026 Results

    Strong year-over-year growth supported by Canadian leadership and growing international sales, improving gross margin. Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share1, is pleased to announce its results for the first quarter ended December 31, 2025 ("Q1 Fiscal 2026" or "Q1"). Q1 FISCAL 2026 HIGHLIGHTS Gross Revenue: $97.3 million (+46% year-over-year). Net Revenue: $63.5 million (+49% year-over-year). International Revenue: $5.0 million (+51% year-over-year). Adjusted EBITDA2: $5.3 million (+273% year-over-year). #1 Market Share in Canada: #1 in vapes, #1 in milled flower, #1 in concentrates, #2

    2/10/26 6:00:00 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Organigram to Report First Quarter Fiscal 2026 Results on February 10, 2026

    Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share, announced today it will report earnings results for its first quarter fiscal 2026 ended December 31, 2025, on Tuesday, February 10, 2026, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Tuesday, February 10, 2026 Time: 8:00 am Eastern Time To register for the conference call, please use this link: https://events.q4inc.com/analyst/430252525?pwd=WEt2KbHS To ensure you are connected for the full call, we suggest registering a day in advance or at minimum 10 minutes before the start of the call.

    2/3/26 6:00:00 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Village Farms Recognized for Export Leadership at BC Export Awards

    DELTA, British Columbia, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Village Farms International, Inc. ("Village Farms" or the "Company") (NASDAQ:VFF), is proud to announce that it has been named the winner of Business in Vancouver's (BIV) 2026 BC Export Awards in the Consumer Products category, recognizing the Company's exceptional export performance and its contribution to British Columbia's growing international trade economy. Driven by its operational capabilities and the vision of its global commercial and medical leadership teams, Village Farms has rapidly scaled international exports to many of the world's most highly regulated markets through its EU-GMP certified operations at its 4.8 milli

    1/26/26 7:00:00 AM ET
    $VFF

    $CARA
    $OGI
    $PMD
    $VFF
    SEC Filings

    View All

    SEC Form 6-K filed by Organigram Global Inc.

    6-K - ORGANIGRAM GLOBAL INC. (0001620737) (Filer)

    2/3/26 11:10:05 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by Organigram Global Inc.

    6-K - ORGANIGRAM GLOBAL INC. (0001620737) (Filer)

    1/27/26 7:33:11 PM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    22nd Century Group Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Material Modification to Rights of Security Holders, Financial Statements and Exhibits

    8-K - 22nd Century Group, Inc. (0001347858) (Filer)

    1/22/26 8:00:48 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    $CARA
    $OGI
    $PMD
    $VFF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Chief Executive Officer Degiglio Michael A bought $30,150 worth of shares (25,000 units at $1.21), increasing direct ownership by 0.26% to 9,783,127 units (SEC Form 4)

    4/A - Village Farms International, Inc. (0001584549) (Issuer)

    6/3/25 9:00:14 PM ET
    $VFF

    Chief Financial Officer Degiglio Michael A bought $30,150 worth of shares (25,000 units at $1.21), increasing direct ownership by 0.26% to 9,783,127 units (SEC Form 4)

    4 - Village Farms International, Inc. (0001584549) (Issuer)

    6/2/25 6:17:22 AM ET
    $VFF

    Chief Financial Officer Ruffini Stephen C bought $30,150 worth of shares (25,000 units at $1.21), increasing direct ownership by 0.26% to 9,783,127 units (SEC Form 4)

    4 - Village Farms International, Inc. (0001584549) (Issuer)

    6/2/25 6:12:58 AM ET
    $VFF

    $CARA
    $OGI
    $PMD
    $VFF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Mclernon John R. converted options into 65,790 shares and covered exercise/tax liability with 17,168 shares, increasing direct ownership by 59% to 130,642 units (SEC Form 4)

    4 - Village Farms International, Inc. (0001584549) (Issuer)

    12/29/25 4:03:37 PM ET
    $VFF

    Director Holewinski David converted options into 65,790 shares, increasing direct ownership by 47% to 204,310 units (SEC Form 4)

    4 - Village Farms International, Inc. (0001584549) (Issuer)

    12/29/25 4:03:07 PM ET
    $VFF

    Director Mahoney Kathleen M converted options into 65,790 shares, increasing direct ownership by 129% to 116,810 units (SEC Form 4)

    4 - Village Farms International, Inc. (0001584549) (Issuer)

    12/29/25 4:02:42 PM ET
    $VFF

    $CARA
    $OGI
    $PMD
    $VFF
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Canaccord Genuity initiated coverage on Organigram Global

    Canaccord Genuity initiated coverage of Organigram Global with a rating of Buy

    1/27/26 9:29:20 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Canaccord Genuity resumed coverage on OrganiGram

    Canaccord Genuity resumed coverage of OrganiGram with a rating of Speculative Buy

    7/17/24 12:18:49 PM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cara Therapeutics downgraded by Stifel with a new price target

    Stifel downgraded Cara Therapeutics from Buy to Hold and set a new price target of $1.00 from $6.00 previously

    6/13/24 7:05:24 AM ET
    $CARA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CARA
    $OGI
    $PMD
    $VFF
    Financials

    Live finance-specific insights

    View All

    Organigram Reports First Quarter Fiscal 2026 Results

    Strong year-over-year growth supported by Canadian leadership and growing international sales, improving gross margin. Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share1, is pleased to announce its results for the first quarter ended December 31, 2025 ("Q1 Fiscal 2026" or "Q1"). Q1 FISCAL 2026 HIGHLIGHTS Gross Revenue: $97.3 million (+46% year-over-year). Net Revenue: $63.5 million (+49% year-over-year). International Revenue: $5.0 million (+51% year-over-year). Adjusted EBITDA2: $5.3 million (+273% year-over-year). #1 Market Share in Canada: #1 in vapes, #1 in milled flower, #1 in concentrates, #2

    2/10/26 6:00:00 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Organigram to Report First Quarter Fiscal 2026 Results on February 10, 2026

    Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share, announced today it will report earnings results for its first quarter fiscal 2026 ended December 31, 2025, on Tuesday, February 10, 2026, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Tuesday, February 10, 2026 Time: 8:00 am Eastern Time To register for the conference call, please use this link: https://events.q4inc.com/analyst/430252525?pwd=WEt2KbHS To ensure you are connected for the full call, we suggest registering a day in advance or at minimum 10 minutes before the start of the call.

    2/3/26 6:00:00 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Organigram Reports Record Fourth Quarter and Fiscal 2025 Results

    Record annual revenue, adjusted EBITDA1, and international sales. Organigram Global Inc (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), Canada's #1 recreational cannabis company by market share2, is pleased to announce record results for the fourth quarter and twelve months ended September 30, 2025 ("Q4 Fiscal 2025" or "Fiscal 2025"). All financial information in this press release is expressed in Canadian dollars ("$"). FOURTH QUARTER 2025 FINANCIAL HIGHLIGHTS Gross Revenue: $123.3 million (+76% year-over-year). Net Revenue: $80.1 million (+79% year-over-year). Adjusted Gross Margin1: $30.6 million or 38%. Adjusted EBITDA1: $9.8 million (+69% year-over-year). FISCAL 20

    12/16/25 6:00:00 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CARA
    $OGI
    $PMD
    $VFF
    Leadership Updates

    Live Leadership Updates

    View All

    Village Farms International Creates Global Strategy Officer Role and Appoints Brian Stevenson

    Proven tobacco, pharmaceutical, and cannabis executive will lead the Company's enterprise-wide strategic agenda Appointment underscores the Company's commitment to disciplined global expansion and long-term value creation LAKE MARY, Fla., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Village Farms International, Inc. ("Village Farms" or the "Company") (NASDAQ:VFF), today announced the appointment of Brian Stevenson to the role of Global Chief Strategy Officer. In this newly created role, Mr. Stevenson will lead the Company's enterprise-wide strategic agenda, including long-term growth strategy, global market assessment, and integration initiatives across regions and business units. Mr. Stevenson wil

    12/17/25 4:30:00 PM ET
    $VFF

    Organigram Announces Appointment of Chief Executive Officer

    Organigram Global Inc. ("Organigram" or the "Company") (TSX:OGI) (NASDAQ:OGI), the parent company of Organigram Inc., a leading Canadian producer of cannabis, is pleased to announce that James Yamanaka, formerly Global Head of Strategy for British American Tobacco, has been appointed the Company's new Chief Executive Officer (CEO). Mr. Yamanaka is expected to assume the role effective on or about January 15, 2026. Mr. Yamanaka will also join the Company's board of directors when he assumes the role of Chief Executive Officer. Mr. Yamanaka is a seasoned executive, having spent more than 20 years at British American Tobacco, with extensive experience in strategy and general management across

    11/25/25 6:00:00 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Village Farms Launches Promenade Brand's First Vape in Quebec

    HUNTINGDON, Quebec, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Village Farms International, Inc. (NASDAQ:VFF), together with its Quebec-based subsidiary Rose LifeScience Inc., today announced the launch of Promenade's first vape product, Matin. This introduction marks a major step forward for Quebec's regulated cannabis market, as Promenade becomes one of the first brands to join the province's new vape category. While meaningful progress has been made in shifting consumers from the illicit to the legal market, the absence of a regulated vape category in Québec until now has limited consumer access to this format. An estimated 21 percent of Québec cannabis consumers previously turned to out-of-pro

    11/24/25 7:00:00 AM ET
    $VFF

    $CARA
    $OGI
    $PMD
    $VFF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Psychemedics Corporation

    SC 13D/A - PSYCHEMEDICS CORP (0000806517) (Subject)

    12/12/24 5:15:40 PM ET
    $PMD
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13D/A filed by Organigram Holdings Inc.

    SC 13D/A - ORGANIGRAM HOLDINGS INC. (0001620737) (Subject)

    12/10/24 7:10:15 PM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Psychemedics Corporation

    SC 13G/A - PSYCHEMEDICS CORP (0000806517) (Subject)

    12/6/24 9:18:20 PM ET
    $PMD
    Medical Specialities
    Health Care